Mystic Pharmaceuticals CEO To Present At HHS BARDA Public Health Emergency Medical Countermeasures Workshop
Mystic Pharmaceuticals(TM), Inc. (www.mysticpharmaceuticals.com):
Mystic Pharmaceuticals President and CEO Timothy Sullivan will present at HHS BARDA STAKEHOLDERS WORKSHOP 2008 FOR PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURES, September 24-26, 2008 at the Crystal Gateway Marriott in Arlington, VA.
The HHS Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2008 and BARDA Industry Day will bring together public and private sector stakeholders for a dynamic dialogue on the current state of medical countermeasure preparedness, PHEMCE initiatives in the past year and plans for moving forward to enhance national capabilities to respond to a public health emergency.
Timothy Sullivan will present on the topic of Advanced Intranasal Delivery for Packaging, Stockpiling and Dispensing Liquid and Reconstituted Emergency Vaccines and Bioterror Countermeasures in Chaotic and Austere Conditions. He will provide an update on Mystic’s VersiDoser(TM) and VRx2(TM) Drug and Vaccine Delivery Platforms and announce new research and development collaborations for the application of Mystic’s delivery technology for pandemic and bioterror medical countermeasures.
Timothy Sullivan will present on Wednesday, September 24 at 2:00 pm in Salon VI of the Crystal Gateway Marriott in Arlington, VA.
About Mystic Pharmaceuticals, Inc.
Mystic Pharmaceuticals(TM) is an integrated specialty pharmaceutical company based in Austin, Texas. Mystic develops precision unit dose drug delivery technology platforms for pharmaceuticals, biologic agents, vaccines and other compounds for ophthalmic and intranasal applications. Mystic combines its novel drug delivery systems with a pipeline of pharmaceuticals and biologics under development by Mystic or its partners, to meet the expanding global market demand for pharmaceuticals, biopharmaceuticals and vaccines which are lower cost, simplified administration and provide enhanced compliance for consumers.
For more information please visit the Mystic website: www.mysticpharmaceuticals.com
